PCYC
PCYC Articles
With a couple of exceptions, the short interest in biotech stocks is on the rise again, judging by the short interest changes from September 14 settlement date versus the August 31 settlement date....
Published:
The short interest in biotech stocks is generally falling, judging by the short interest changes from August 31 settlement date versus the August 15 settlement date. We have tracked the key short...
Published:
Jon OggThese are the top analyst calls of upgrades, downgrades, and initiations we have seen from Wall St. research calls this Tuesday morning. AK Steel Holding Corp. (NYSE: AKS) cut to Sell at UBS....
Published:
Last Updated:
The short interest in biotech stocks is generally rising, judging by the short interest changes from August 15 settlement date versus the July 31 settlement date. We have tracked the key short...
Published:
Jon OggThese are the top analyst calls of upgrades, downgrades and initiations we have seen from Wall St. research calls this Friday morning. Abercrombie & Fitch Co. (NYSE: ANF) maintained...
Published:
Last Updated:
What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to wonder which other peers and competitors might be on the M&A block. Monday’s...
Published:
Last Updated:
More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks associated with future regulation under health care, but deals in the biotech and emerging...
Published:
Last Updated:
The freshly announced multibillion biotech buyout of Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) for more than $5 billion in equity value may be a bit misleading if you consider that it is...
Published:
Last Updated:
We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) is set to take...
Published:
Last Updated:
It is now getting close to the middle of May, and that means one thing for biotech investors. The king of biotech and pharma events is about to take place. The 2012 annual meeting of the American...
Published:
Last Updated:
All three major US stock indexes opened lower this morning and the day was mostly a gentle slide for the rest of the trading session. The failed Greek debt deal weighed on futures this morning and...
Published:
Last Updated:
Equity markets opened higher this morning as an agreement on dealing with the Eurozone’s debt crisis boosted markets. Shares climbed during the day, recovering some of the losses in yesterday’s...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Friday morning. Citigroup, Inc. (NYSE: C) Started as Equal-Weight by Evercore...
Published:
Last Updated:
Today’s edition of the BioHealth Business Daily is going to be very cancer-dominated due to the American Society of Clinical Oncology (ASCO) 2010 meeting that started this last weekend. There are...
Published:
Last Updated: